Log In
Print
BCIQ
Print
Print this Print this
 

Ovasave

  Manage Alerts
Collapse Summary General Information
Company TxCell S.A.
DescriptionAntigen-specific type 1 regulatory T cell based immunotherapy
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today